Cyteir Therapeutics, Inc.
Cyteir Therapeutics, Inc. logo
CYT

Cyteir Therapeutics, Inc. (CYT)

$1.442.13%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$1.37
Day's Range
$1.5
$1.37
52-Week Range
$16.88
1 month return20.0%
3 month return30.43%
1 year return90.18%
5 year return92.38%

Company Information

Cyteir is a clinical-stage oncology company that is focused on the discovery and development of next-generation synthetically lethal therapies to treat cancer. The company is using its expertise in DNA damage response biology to advance a pipeline of novel drug candidates that selectively target key cancer vulnerabilities. Cyteir’s wholly owned lead compound, CYT-0851, is a potent and selective, oral investigational drug that was designed to inhibit RAD51-mediated homologous recombination and the repair of double-strand DNA breaks.
OrganizationCyteir Therapeutics, Inc.
Employees40
CEOMr. Joseph S. Zakrzewski
IndustryServices

Analyst Recommendation

based on 8 analysts ratings

Buy
75%
Buy
25%
Hold
0%
Sell

Based on 8 Wall street analysts offering stock ratings for Cyteir Therapeutics, Inc.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 270.14%

Current

$1.44

Target

$5.33

Recommendation Trend

Based on 8 analyst

Current1M Ago3M Ago
Buy
6
7
8
Hold
2
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
50.0M
Book Value
$4.36
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
5.45
PE Ratio
0.26
Wall Street Target Price
5.33

Valuation

Trailing PE0.26
Forward PE0.0
Price/Book (mrq)
0.32
Enterprise Value
-103021135
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
2.09

Technicals

50 Day MA
1.79
200 Day MA
2.79

Institutional Holdings

Novo A/S

13.69%

FMR Inc

10.95%

Baker Bros Advisors LP

7.48%

OUP Management Co., LLC

6.99%

Avidity Partners Management LP

5.11%

CAAS CAPITAL MANAGEMENT LP

1.74%

Discover more

Frequently Asked Questions

What is Cyteir Therapeutics, Inc. share price today?

Can Indians buy Cyteir Therapeutics, Inc. shares?

How can I buy Cyteir Therapeutics, Inc. shares from India?

Can Fractional shares of Cyteir Therapeutics, Inc. be purchased?

What are the documents required to start investing in Cyteir Therapeutics, Inc. stocks?

What are today’s High and Low prices of Cyteir Therapeutics, Inc.?

What are today’s traded volumes of Cyteir Therapeutics, Inc.?

What is today’s market capitalisation of Cyteir Therapeutics, Inc.?

What is the 52 Week High and Low Range of Cyteir Therapeutics, Inc.?

How much percentage Cyteir Therapeutics, Inc. is down from its 52 Week High?

How much percentage Cyteir Therapeutics, Inc. is up from its 52 Week low?

What are the historical returns of Cyteir Therapeutics, Inc.?

Who is the Chief Executive Officer (CEO) of Cyteir Therapeutics, Inc.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*